Recent Updates
Recently added Catalysts

Tecnis ZCB00 IOL , Toric Intraocular lens

Phase 3

Cataract | Unknown | Ophthalmology |Abbott Laboratories|Last Updated: Feb 4, 2025

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindACTIVE_CONTROLLEDBiomarker
Total Trials1
Total Enrollment269
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01098812Clinical Evaluation of a 1-Piece Intraocular LensPHASE3 COMPLETED 269Mar 1, 2010Oct 1, 2011Feb 4, 2025 -
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Mean Percent Reduction in Cylinder
6 months after second eye implant compared to baseline

Reduction in cylinder postoperatively vs. preoperatively (baseline) as measured by keratometry and manifest refraction. Mean percent reduction in cylinder = (postoperative refractive cylinder minus preoperative keratometric cylinder)/(target refractive cylinder minus preoperative keratometric cylinder). Reduction in cylinder was assessed in the first eye (per participant) for contribution to the mean.

Secondary Endpoints
Uncorrected Distance Visual Acuity (UCDVA)
6 months after second eye implant
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingDOUBLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Control IOLACTIVE_COMPARATORApproved Intraocular control lens
Toric IOLEXPERIMENTALInvestigational Toric IOL
Higher Cylinder Toric IOLEXPERIMENTALInvestigational Toric IOLs with higher cylinder powers.
Interventions
NameTypeDescription
Tecnis ZCB00 IOL (control)DEVICETecnis 1-piece acrylic IOL
Toric Intraocular lensDEVICEToric acrylic intraocular lens with various cylinder powers
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersYes

Inclusion Criteria: * Minimum 18 years of age * Cataract for which phacoemulsification extraction and posterior chamber IOL implantation has been planned for both eyes * Preoperative best corrected distance visual acuity (BCDVA)of 20/40 or worse (Snellen), with or without glare, for each eye * BCDV...

Unlock Eligibility Criteria